The trial hasn’t even started yet, but Mets owner Fred Wilpon is already going to have to shell out as much as $83.3 million to the trustee recovering funds from the losers in Bernard Madoff’s Ponzi scheme.
That was the ruling from U.S. District Court Judge Jed S. Rakoff on Monday. The two sides will go to trial on March 19 over the additional $303 million that trustee Irving Picard is seeking. For Picard to extract that much from Wilpon’s wallet, he’ll need to prove to a jury that the defendants were “willfully blind” to the fraud.
Rakoff had previously ruled that Picard couldn’t sue the Wilpons for the full $1 billion he wanted, lowering that amount instead to the $386 million they were said to profit in the two years preceding Madoff’s arrest. Today’s $83.3 million comes out of that.
It’s unclear if the Wilpons have $83.3 million to give away at this time. They have been trying to sell minority shares of the Mets, with mixed reports of their success in the endeavor. If the trial goes poorly later this month, it figures to be difficult for them to keep the team.
Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.
Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.
While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.